English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduUsing an AI-driven decision support system to predict the severity of COVID-19 and identify best interventions, researchers analyzed electronic health record data from 5,371 patients admitted to a South Florida hospital. The study specifically aimed to forecast the likelihood of patients requiring admission to an ICU, with or without mechanical ventilation, or an intermediate care unit (IMCU). The goal was to leverage these features to enable faster and more accurate forecasting of treatment plans, potentially preventing critical conditions from worsening.
Tag: Treatment
New device would help those with chronic conditions get timely treatment
Husker engineer Eric Markvicka is developing a new approach for detecting acute exacerbations of chronic conditions.
Florida Atlantic University Parkinson’s Expert Available
Dr. Michael R. Dobbs, from Florida Atlantic University Schmidt College of Medicine, comments on Parkinson’s Disease: “It takes a lot of courage for a celebrity to share that they have Parkinson’s disease. By coming forward, they not only reveal their personal…
Penny for Your Thoughts? Master Copper Regulator Discovery May Offer Alzheimer’s Clues
A groundbreaking study using a tiny roundworm could pave the way for new treatments for neurodegenerative disorders. Researchers have linked the worm gene swip-10 to copper regulation – a vital element for brain health found in everyday items like wiring and cookware. Understanding the roles of swip-10 and MBLAC1, a protein involved in processing cellular materials, could lead to the development of effective medications and opens new avenues for advancing brain disease treatments.
National Academy of Medicine Selects FAU for Substance Use, Opioid Crises Collaborative
FAU joins the National Academy of Medicine’s Action Collaborative on Combating Opioid Crises. This pilot project, involving more 80 organizations, aims to enhance coordination and address addiction challenges through collaboration among public, private and nonprofit sectors.
UK HealthCare opens 1st EmPATH psychiatric emergency unit in Kentucky
Community and state leaders joined UK HealthCare officials on July 30 to celebrate the opening of a new emergency unit dedicated to the treatment of patients experiencing a mental health crisis.The unit, known as EmPATH (Emergency Psychiatric Assessment, Treatment and Healing), is the first EmPATH unit in Kentucky.
Uncontrolled Hypertension: The Old ‘Silent Killer’ is Alive and Well
High blood pressure affects about 45% of U.S. adults. In the 1970s, only about 50% of patients were aware of their hypertension. Today, 54% are aware of their high blood pressure, 40% are actively treated and 21% are actively controlled. As such, researchers alert health care providers that the old “silent killer” is alive and well.
Advancing regenerative medicine therapies
University and community guests recently gathered to celebrate the 7,700 square-foot Good Manufacturing Practice facility’s grand opening in Hewitt Hall’s basement on the UC Irvine campus. Although the highly sterile environment remains off-limits for tours, the gala highlighted its importance to the campus, the UC system and the local community.
Mount Sinai Health System named 2024 Hearst Health Prize winner
Hearst Health and the UCLA Center for SMART Health awarded the 2024 Hearst Health Prize to Mount Sinai Health System. Mount Sinai Health System was declared the winner for a machine learning application called NutriScan AI that facilitates faster identification and treatment of malnutrition in hospitalized patients.
ASCO: Proton therapy demonstrates advantages in Phase III head and neck cancer trial
According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy (IMRT) as part of chemoradiation treatment for patients with oropharyngeal (head and neck) cancer.
Transforming burn treatment: global consensus on second-degree wound care
In a significant development for medical professionals, a new consensus has been developed to enhance the treatment of second-degree burn wounds. This guideline offers a thorough and systematic method for addressing these frequently occurring injuries, advocating for a standardized approach to care.
Promising New Treatment for Patients with HR+ HER-2 Negative Metastatic Breast Cancer
New research from Yale Cancer Center reveals first-of-its-kind data from a phase I study in patients with hormone receptor positive HER2-negative metastatic breast cancer. The results, which assess the safety and efficacy of a treatment known as PF-07248144, offer new hope for treating this aggressive type of breast cancer.
FAU Researchers Receive $1M in FDOH Grants to Fight Alzheimer’s Disease
With this funding, FAU researchers will shed light on the biological functions of Alzheimer’s disease (AD) by taking advantage of synthetic chemistry strategies; provide an innovative online screening tool for older drivers with cognitive decline; and gain a deeper understanding of the role of brain cholesterol in AD.
Study Examines U.S. Public Opinion of ‘Would-be’ Mass Shooters
A first-of-its-kind study sheds light on public opinion about would-be mass shooters, particularly regarding their mental health status. Willingness to “see something” and “say something,” especially when loved ones or associates are involved, hinges on whether the informant believes the criminal justice system will handle the situation effectively and fairly.
Magic mushrooms can treat medication-resistant depression. But are they safe?
Commonly referred to as “magic mushrooms,” psilocybin is a promising alternative treatment for people with medication-resistant depression and anxiety.
Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease.
FDA Approves App To Help Treat Depression
Rhonda Schwindt, is an associate professor at the GW School of Nursing. She is a nationally certified psychiatric-mental health nurse practitioner with an active clinical practice specializing in LGBTQIA+ health, trauma, and treatment-resistant mood disorders. Amir Afkhami, an expert in…
JMIR Dermatology Invites Submissions on Diversity in Dermatology
JMIR Publications is pleased to announce a new theme issue titled “Diversity in Dermatology” in JMIR Dermatology. The premier, peer-reviewed journal is indexed in Sherpa Romeo, Scopus, DOAJ, CABI, and PubMed Central/PubMed and is the official journal of the International Society of Digital Health in Dermatology (ISDHD).
Podcast: Experts in Health: The menopause and the controversial ‘male menopause’
Professor Eef Hogervorst, Professor of Biological Psychology at Loughborough University, sits down to discuss the factors influencing the menopause, what the best treatment options are, the relationship between oestrogen and dementia, and the controversies surrounding the andropause (the ‘male menopause’).
New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial
An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer with few effective treatment options, according to results from a clinical trial led by Queen Mary University of London.
Prof. Dr. Thanyavee Puthanakit, National Outstanding Researcher in Medical Science, with Clinical Research on the Treatment and Prevention of HIV in Youth
Prof. Dr. Thanyavee expressed her appreciation and honor for receiving the Outstanding Researcher Award.
New treatment developed to dramatically slow down the progression of blindness-causing retinal diseases
The Korea Institute of Science and Technology (KIST) announced that Dr. Maesoon Im of the Brain Science Institute, together with Prof. Seung Ja Oh of Kyung Hee University and Prof. Kangwon Lee of Seoul National University, successfully incorporated anti-inflammatory drugs into a hydrogel to suppress inflammation in the retina and effectively deliver the drugs to the inflamed area.
Strongest contender in decades in fight against breast cancer
For decades, hormonal treatment of breast cancer has been going in one direction – blocking estrogen.
Novel Treatment Regimen for FLT3-Mutated Acute Myeloid Leukemia Shows Promise in Roswell Park-Led Study
Up to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene mutation, which is associated with a high risk of relapse and a very poor prognosis.
New Prostate Cancer Report Card keeps treatment options simple to understand
A new prostate cancer resource – the Prostate Cancer Outcomes Report Card – hopes to make it easier for men and their families to better understand the treatment options and outcomes.
Residents of Rural ‘Glades’ Take a ‘Leap of Faith’ to Combat Dementia
Compared to urban dwellers, racially/ethnically diverse older adults face up to an 80 percent greater risk of cognitive impairment in older age, and 2.5 times potentially preventable Alzheimer’s-related (ADRD) hospitalizations.
World’s Largest Meeting of Eye Physicians and Surgeons Spotlights Advances in Artificial Intelligence
AAO 2023 delivers opportunities to hear from the greatest minds in medical and surgical eye care discuss the latest scientific breakthroughs in vision treatment and research.
NIH grants support UCLA and Charles Drew University researchers’ efforts to end HIV epidemic
The National Institutes of Health (NIH) has granted $2.1 million to UCLA’s Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-CDU Center for AIDS Research (CFAR) to support four research projects and an implementation science consultation hub.
Study provides preliminary evidence in favor of a new type 1 diabetes treatment
A new study led by researchers at UChicago Medicine and Indiana University suggests that an existing drug could be repurposed to treat type 1 diabetes, potentially reducing dependence on insulin.
Oregon State researchers uncover mechanism for treating dangerous liver condition
A study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved medications.
Preventing collateral damage in cancer treatment
Using a simple concept and a patented Sandia sensor that detects radioactive materials, a team at Sandia National Laboratories has developed a patch to stop damage to healthy tissue during proton radiotherapy, one of the best tools to target certain cancerous tumors.
New study suggests promising approach for treating pancreatic cancer
A new study carried out in mice, led by Queen Mary University of London, has identified cells that drive the spread of pancreatic cancer and discovered a weakness in these cells that could be targeted using existing drugs. This offers a promising new approach for treating pancreatic cancer.
New 3D-printed tumor model enables faster, less expensive and less painful cancer treatment
Researchers combining bioprinting with synthetic chips to understand tumors in 3D
Brain tumor treatment by targeting TUG1, a gene that controls replication stress
A new study has unravelled a crucial link between how cancer cells cope with replication stress and the role of Taurine Upregulated Gene 1 (TUG1). By targeting TUG1 with a drug, the researchers were able to control brain tumor growth in mice, suggesting a potential strategy to combat aggressive brain tumors such as glioblastomas.
Copycat nutrient leaves pancreatic tumors starving
A study led by scientists at Sanford Burnham Prebys suggests an entirely new approach to treat pancreatic cancer. The research shows that feeding tumors a copycat of an important nutrient starves them of the fuel they need to survive and grow.
Blood-based biomarker may redefine the future treatment for advanced melanoma
Circulating tumor DNA (ctDNA) is emerging as a blood-based biomarker for many solid tumor types, including melanoma.
New study reveals Australian Long COVID response lagging
New research by RMIT University and Northern Health has examined Australia’s Long COVID services, guidelines and public health information, compared with international standards.
Pregnant women offered new hope for safe and effective gestational diabetes treatment
Researchers at University of Galway have taken a significant step forward in the management of gestational diabetes mellitus after a clinical trial involving pregnant women provided new hope for expectant mothers suffering the condition.
Researchers Discover Promising Treatment to Combat Hospital Superbug
Cal State Fullerton antibiotic-resistance researcher María Soledad Ramírez and her students have discovered a promising new therapeutic to treat Acinetobacter baumannii, a superbug commonly found in hospitals and resistant to many antibiotics.
Susan G. Komen® Analysis Shows Many Breast Cancer Patients Struggle To Afford Basic Needs: Housing, Transportation, Utilities
Lower income breast cancer patients often struggle to afford life’s necessities such as housing, transportation and utilities due to direct and incidental costs related to their treatment, according to a new analysis by Susan G. Komen®.
Palex and Inbiomotion introduce pioneering test to aid oncologists in predicting recurrence and survival rates in breast cancer patients
Spain is the first country in the world to have this technology
• Results showing the clinical utility of the test were published in
Lancet Oncology and the Journal of National Cancer Institute
• The test is now available to oncologists and pathologists and will
benefit an estimated 24,000 patients each year in Spain
Mechanism of adipose-derived mesenchymal stem cell exosomes in the treatment of heart failure
BACKGROUNDHeart failure (HF) is a global health problem characterized by impaired heart function. Cardiac remodeling and cell death contribute to the development of HF. Although treatments such as digoxin and angiotensin receptor blocker dr
Researchers pioneer safe chemotherapy methods for treating bacterial infections
Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow.
U.S. States Maintain Outdated Laws That Create Barriers to Screening and Treatment for Alcohol Use Disorder
Eighteen U.S. states have laws that allow insurance companies to deny health care payments to treat people who were intoxicated when they sustained an injury, despite evidence showing that these laws prevent people from receiving treatment for alcohol use disorder and shift costs from insurance companies to the health care system, the government, individuals and families.
Francine Foss, MD, in honor of Blood Cancer Awareness Month
As we honor lymphoma awareness month, what do you want our patients and families to pause and remember?Lymphoma is a disease which can strike any one of us, young and old, at any time.
“Stereotyped, devalued and shunned.” Experts address treating the stigma of Parkinson’s disease
Even the best treatment approaches for Parkinson’s disease are inadequate if they do not address patients’ feelings of social rejection, isolation, loneliness and other psychosocial effects of stigma, according to a report from experts specializing in Parkinson’s and other movement disorders.
New immunotherapy treatment brings hope to patients with advanced non-small cell lung cancer
Although immunotherapies have shown promise in treating non-small cell lung cancer (NSCLC), many patients still do not respond well, and those who do may eventually develop resistance.
Capturing the Chemistry of Radium-223 for Cancer Treatment
Researchers seeking to improve the use of radium-223 to target cancer cells investigated how the isotope interacts with two chelators, macropa and DOTA. Experiments and computer-driven models discovered that macropa is the strongest chelator for binding radium identified so far.
Expert Addresses Stigma, Disparities in Prostate Cancer
David M. Golombos, MD, addresses prostate cancer topics
Dr. Charles Park and Dr. Jon McIver of The Minimally Invasive Brain and Spine Center at Mercy are Featured Guests for the September 2023 edition of “Medoscopy”
Charles C. Park, M.D., Ph.D., and Jon I. McIver, M.D., neurosurgeons with The Minimally Invasive Brain and Spine Center at Mercy, are featured guests on Mercy’s monthly talk show, “Medoscopy”, September 20th-21st at 5:30 p.m. EST.